Get In Touch

Allergy is the harmful immune reaction produced by the body to a specific substance or allergen such as dust, pollen, mite, and food. Treatment of allergy generally consists of use of anti-allergy drugs and immunotherapy. These anti-allergy drugs or immunotherapy treatment reduces the allergic reaction caused due to an allergen by decreasing its sensitivity. Immunotherapy has become the most prominent treatment for various allergic diseases in the past few years. Immunotherapy acts by curing the root cause of allergy. This therapy effectively controls and manages the clinical symptoms, reduces or eliminates the need for medication, prevents the worsening of a disease, and reduces the degree of specific and nonspecific bronchial hyperactivity. Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are the two types of immunotherapy. Acceptance of immunotherapy is rising in developed as well as developing countries owing to its positive results.

Sublingual immunotherapy exposes a patient to an allergic substance or an allergen repeatedly over a period of time to induce tolerance against that allergic substance. An allergen in the form of drops or a tablet is placed under the tongue. This therapy has been extensively used in Europe for the past 20 years to treat various allergies. Sublingual immunotherapy has several benefits. A major benefit is less risk of severe reactions to tablets or drops as compared to injections. Additionally, once the doctor has administered the first dose of SLIT, the patient can take the further doses by self at home. No more visits to the doctor or medical clinic are required for administration of the dose. Moreover, this therapy is simple, safe, and highly effective in treating allergies. These benefits are anticipated to boost the growth of the global sublingual immunotherapy market during the forecast period.

Sublingual immunotherapy, or allergy shots, is a long-term treatment for allergic disease such as allergic asthma, allergic rhinitis, allergic conjunctivitis (eye allergy), or insect allergy.  Immunotherapy is a next generation treatment for allergy and it can modify the natural course of a disease. Increase in prevalence of allergies is a key driver of the global sublingual immunotherapy market. In 2015, prevalence of allergic diseases globally was estimated to be 20% to 30% of the world’s population, which is about 1 billion people suffering from some kind of allergies. Allergic rhinitis affects most of the population across the world. According to the World Allergy Organization (WAO), about 400 million people worldwide are affected by allergic rhinitis. Sublingual immunotherapy therapy is highly used in the treatment of allergic rhinitis. Increase in environmental pollution contributes to the growth of the sublingual immunotherapy market.

The global sublingual immunotherapy market can be segmented based on product type, distribution channel, and region. In terms of product type, the market can be categorized into drops and tablets. The U.S. Food Drug and Administration (FDA) has approved three allergy tablet products: Oralair, Grastek, and Ragwitek. Currently, there are no FDA-approved liquid drops available in the market. This provides an opportunity for pharmaceutical companies to invest and gain a foothold in the global sublingual immunotherapy drops market. Based on distribution channel, the market can be classified into hospital pharmacies, retail pharmacies and drug stores, and online pharmacies.

In terms of region, the global sublingual immunotherapy market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America dominates the global market because of fast growing life science industry, rise in focus on research & new drug development, and increase in the number of pharmaceutical companies focusing on immunotherapy. Europe is the second largest market for sublingual immunotherapy. Most of the immunotherapy drugs are approved in Europe and adoption of the therapy is likely to increase rapidly during the forecast period. Asia Pacific is projected to be the most lucrative market for sublingual immunotherapy and is expected to expand at the highest growth rate from 2017 to 2025. Rise in government initiatives, grants, and funds; increase in life science R&D spending, especially in India, China, and Japan, and dedicated research commercial zones are attracting domestic and foreign players to invest and enter the lucrative research sector in Asia Pacific.

Key players operating in the global sublingual immunotherapy market include Allergon AB (Thermo Fisher Scientific, Inc.), HAL Allergy Group, Allergy Therapeutics, Stallergenes Greer, and ALK.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Sublingual Immunotherapy Market

Pre Book